News

A clinical trial for motor neurone disease (MND) patients will proceed thanks to a funding boost from FightMND.

Cutting-edge research at the Australian Institute of Bioengineering and Nanotechnology has won Australia’s most prestigious awards.

Three Early Career Researchers at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) have been awarded nearly $2 million in Investigator Grants from the National Health and Medical Research Council (NHMRC).

At AIBN, we are always happy to hear about the bright paths being forged by former students and researchers, which is why we’re very excited by recent news about former AIBN Honours student Dr James Briggs.

A facility headquartered at AIBN has received $4.59 million from the Queensland Government to continue its innovative research and industry projects such as needle-free vaccine delivery.

AIBN's Associate Professor Claudia Vickers has been been named as one of the Australian Financial Review’s Boss Magazine’s True Leaders of 2019.

An Australian gold mining company will aid the development of a rapid cancer test with a $300,000 donation to AIBN.

AIBN would like to extend a warm congratulations to the Spinifex Nanocellulose Pilot Plant Team at Long Pocket for winning a 2019 University of Queensland Excellence Award for Leadership.

Professor Debra Bernhardt, best known in the scientific world for her contribution to deriving the Evans-Searles Fluctuation Theorem, was elected a Fellow of the Australian Academy of Science.

Biofoundry is like a one-stop-shop for synthetic biology R&D, where researchers apply concepts of engineering to biology 

Researchers at The University of Queensland in Australia and Albert Einstein College of Medicine in the US have developed a new statistical method for discovering elusive cancer-promoting genes.

University of Queensland Professor Yusuke Yamauchi, in collaboration with researchers from The University of Tokyo has been awarded the first Rio-Tinto Australia-Japan Collaboration Program Grant.

Professor Lianzhou Wang and his colleagues at AIBN are developing artificial leaves to capture CO2 and convert it into carbon-neutral fuels

Researchers from the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) have discovered a unique nano-scaled DNA signature that appears to be common to all cancers.

The University of Queensland and CSIRO are building a new world-class $4.5 million initiative to boost Australia’s synthetic biology capabilities. The promising new venture was officially announced today at Customs House in Brisbane by UQ Vice-Chancellor Professor Peter Høj and CSIRO Executive Director for Environment, Energy and Resources Dr Peter Mayfield.

University of Queensland (UQ) PhD researcher Kevin Koo has won the inaugural Metrohm Australia-New Zealand Young Chemist of the Year award in recognition of his work in developing nanotechnology-based cancer diagnostics.

Research led by Professor Gordon Xu of the Australian Institute for Bioengineering and Nanotechnology (AIBN) has shown that clay nanoparticles can significantly boost immune responses as vaccine adjuvants.

New research from the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland has brought us a step closer to understanding how protein clumps called amyloid plaques contribute to the death of brain cells in Alzheimer’s disease.

AIBN is delighted to welcome Professor Joe Shapter, a world renowned leader in surface science and scanning probe microscopy.

Increased energy – or metabolic use – in patients with motor neurone disease (MND) has been linked to faster disease progression and reduced lifespan, according to University of Queensland researchers.